Management of Hypertension with Hyponatremia

Rationale for Adding a Diuretic

• The International Society of Hypertension 2020 guidelines explicitly recommend adding a thiazide or thiazide-like diuretic as the third agent when blood pressure remains uncontrolled on an ARB plus calcium channel blocker, creating the preferred three-drug combination of ARB + CCB + diuretic 1
• The patient is already on maximum doses of losartan and amlodipine, making dose escalation impossible, thus adding a diuretic is the next logical step 1

Addressing the Hyponatremia Concern

• If the hyponatremia is determined to be problematic or worsens with diuretic addition, then proceed directly to fourth-line therapy with spironolactone 25 mg daily (or alternatives if contraindicated) 1, 2

Fourth-Line Options if Diuretic is Contraindicated

• The International Society of Hypertension recommends spironolactone when hypertension remains uncontrolled despite maximum doses of ARB + CCB + diuretic 1, 2
• Alternative fourth-line agents include amiloride, doxazosin, eplerenone, clonidine, or beta-blockers if spironolactone is not tolerated or contraindicated 1

Critical Monitoring Parameters

• Recheck sodium levels within 1-2 weeks after adding any new antihypertensive agent, particularly a diuretic 3
• Monitor potassium levels closely, especially if transitioning to spironolactone, as the combination of ARB plus aldosterone antagonist increases hyperkalemia risk 3
• Target blood pressure should be achieved within 3 months of medication adjustment 1

Common Pitfall to Avoid

• Do not skip the diuretic step and jump directly to fourth-line agents without first determining the cause of hyponatremia, as this deviates from evidence-based guidelines 1, 2